Dallas, TX -- (SBWIRE) -- 05/26/2010 -- Dallas, TX ReportsandReports announce it Will Carry Australia Diabetes Care Devices Market Outlook to 2016 Market Research Report in its Store.

Browse the complete Report on: http://www.reportsandreports.com/market-reports/australia-diabetes-care-devices-market-outlook-to-2016/

Summary

GlobalData’s medical equipment offering, “Australia Diabetes Care Devices Market Outlook to 2016” provides key market data on the Australia diabetes care devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

* Market size and company share data for two diabetes care devices market categories – Glucose Monitoring and Insulin Delivery.
* Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories.
* Data from 2002 to 2009, forecast forward for 7 years to 2016.
* 2009 company shares and distribution shares data for each of the two market categories.
* Global corporate-level profiles of key companies operating within the Australia diabetes care devices market. Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Bayer HealthCare AG, Abbott Laboratories, Medtronic, Inc., Becton, Dickinson and Company and Novo Nordisk A/S.

Reasons to buy

* Develop business strategies by identifying the key market categories and segments poised for strong growth.
* Develop market-entry and market expansion strategies.
* Design competition strategies by identifying who-stands-where in the Australia diabetes care devices competitive landscape.
* Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 What is This Report About?

3 Diabetes Care Devices In Australia
3.1 Diabetes Care Devices, Market Segmentation
3.2 Diabetes Care Devices, Australia, Overall Revenue ($m), 2002-2016
3.3 Diabetes Care Devices Market, Australia, Revenue Mix ($m), 2009
3.4 Diabetes Care Devices Market, Australia, Category Contribution (%), 2009
3.5 Diabetes Care Devices, Australia, Category Volume (Units), 2002-2016
3.6 Diabetes Care Devices, Australia, Company Share (2008-2009)

4 Glucose Monitoring In Australia
4.1 Glucose Monitoring, Market Segmentation
4.2 Glucose Monitoring Market, Australia, Revenue Mix ($m), 2009
4.3 Glucose Monitoring Market, Australia, Category Contribution (%), 2009
4.4 Glucose Monitoring Overall Revenue (2002-2016)
4.4.1 Blood Glucose Meters Revenue (2002-2016)
4.5 Glucose Monitoring Overall Volume (2002-2016)
4.5.1 Blood Glucose Meters Volume (2002-2016)
4.6 Glucose Monitoring Average Price (2002-2016)
4.7 Glucose Monitoring Distribution Share (2008-2009)
4.8 Glucose Monitoring, Australia, Company Share (2008-2009)

5 Insulin Delivery In Australia
5.1 Insulin Delivery, Market Segmentation
5.2 Insulin Delivery Market, Australia, Revenue Mix ($m), 2009
5.3 Insulin Delivery Market, Australia, Category Contribution (%), 2009
5.4 Insulin Delivery Overall Revenue (2002-2016)
5.4.1 Insulin Pens Revenue (2002-2016)
5.5 Insulin Delivery Overall Volume (2002-2016)
5.5.1 Insulin Pens Volume (2002-2016)
5.6 Insulin Delivery Average Price (2002-2016)
5.7 Insulin Delivery Distribution Share (2008-2009)
5.8 Insulin Delivery, Australia, Company Share (2008-2009)

6 Overview of Key Companies in Australia Diabetes Care Devices Market
6.1 Novo Nordisk A/S
6.1.1 Company Overview
6.1.2 Share in the Australia Diabetes Care Devices Market
6.2 F. Hoffmann-La Roche Ltd.
6.2.1 Company Overview
6.2.2 Share in the Australia Diabetes Care Devices Market
6.3 LifeScan, Inc.
6.3.1 Company Overview
6.3.2 Share in the Australia Diabetes Care Devices Market
6.4 Sanofi-Aventis
6.4.1 Company Overview
6.4.2 Share in the Australia Diabetes Care Devices Market
6.5 Medtronic, Inc.
6.5.1 Company Overview
6.5.2 Share in the Australia Diabetes Care Devices Market
6.6 Eli Lilly and Company
6.6.1 Company Overview
6.6.2 Share in the Australia Diabetes Care Devices Market
6.7 Bayer HealthCare AG
6.7.1 Company Overview
6.7.2 Share in the Australia Diabetes Care Devices Market
6.8 B. Braun Melsungen AG
6.8.1 Company Overview
6.8.2 Share in the Australia Diabetes Care Devices Market
6.9 Abbott Laboratories
6.9.1 Company Overview
6.9.2 Share in the Australia Diabetes Care Devices Market
6.10 Becton, Dickinson and Company
6.10.1 Company Overview
6.11 Smiths Medical
6.11.1 Company Overview
6.12 Terumo Corporation
6.12.1 Company Overview
6.13 ARKRAY, Inc.
6.13.1 Company Overview
6.14 Apex Biotechnology Corp.
6.14.1 Company Overview
6.15 Animas Corporation
6.15.1 Company Overview
6.16 AiMedics Pty Ltd
6.16.1 Company Overview
6.17 Roche Diagnostics Australia Pty. Ltd.
6.17.1 Company Overview
6.18 National Diagnostics Products Pty. Limited
6.18.1 Company Overview

7 Diabetes Care Devices Market Pipeline Products

8 Appendix
8.1 Definitions of Markets Covered in the Report
8.1.1 Diabetes Care Devices
8.2 Research Methodology
8.3 Secondary Research
8.4 Primary Research
8.5 Models
8.6 Forecasts
8.7 Expert Panels
8.8 GlobalData Consulting
8.9 Currency Conversion
8.10 Contact Us
8.11 Disclaimer

1.1 List of Tables
Table 1:Diabetes Care Devices, Australia, Overall Revenue ($m), 2002-2016
Table 2: Diabetes Care Devices Market, Australia, Category Contribution (%), 2009
Table 3:Diabetes Care Devices, Australia, Cross-Segment Analysis,2002-2016
Table 4:Diabetes Care Devices, Australia, Overall Revenue ($m), Historic, 2002-2009
Table 5:Diabetes Care Devices, Australia, Overall Revenue ($m), Forecast, 2009-2016
Table 6:Diabetes Care Devices, Australia, Category Volume (Units), 2002-2016
Table 7:Diabetes Care Devices, Australia, Category Volume (Units), Historic, 2002-2009
Table 8:Diabetes Care Devices, Australia, Category Volume (Units), Forecast, 2009-2016
Table 9:Diabetes Care Devices, Australia, Company Share by Revenue ($m), 2008-2009
Table 10: Glucose Monitoring Market, Australia, Category Contribution (%), 2009
Table 11:Glucose Monitoring, Australia, Revenue ($m) by Segment, Historic, 2002-2009
Table 12:Glucose Monitoring, Australia, Revenue ($m) by Segment, Forecast, 2009-2016
Table 13:Blood Glucose Meters, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 14:Blood Glucose Meters, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 15:Glucose Monitoring, Australia, Volume (Units) by Segment, Historic, 2002-2009
Table 16:Glucose Monitoring, Australia, Volume (Units) by Segment, Forecast, 2009-2016
Table 17:Blood Glucose Meters, Australia, Volume (Units) by Sub-Segment, Historic, 2002-2009
Table 18:Blood Glucose Meters, Australia, Volume (Units) by Sub-Segment, Forecast, 2009-2016
Table 19:Glucose Monitoring, Australia, Average Price ($), Historic, 2002-2009
Table 20:Glucose Monitoring, Australia, Average Price ($), Forecast, 2009-2016
Table 21:Glucose Monitoring, Australia, Distribution Share by Revenue ($m), 2008-2009
Table 22:Glucose Monitoring, Australia, Company Share by Revenue ($m), 2008-2009
Table 23: Insulin Delivery Market, Australia, Category Contribution (%), 2009
Table 24:Insulin Delivery, Australia, Revenue ($m) by Segment, Historic, 2002-2009
Table 25:Insulin Delivery, Australia, Revenue ($m) by Segment, Forecast, 2009-2016
Table 26:Insulin Pens, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 27:Insulin Pens, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 28:Insulin Delivery, Australia, Volume (Units) by Segment, Historic, 2002-2009
Table 29:Insulin Delivery, Australia, Volume (Units) by Segment, Forecast, 2009-2016
Table 30:Insulin Pens, Australia, Volume (Units) by Sub-Segment, Historic, 2002-2009
Table 31:Insulin Pens, Australia, Volume (Units) by Sub-Segment, Forecast, 2009-2016
Table 32:Insulin Delivery, Australia, Average Price ($), Historic, 2002-2009
Table 33:Insulin Delivery, Australia, Average Price ($), Forecast, 2009-2016
Table 34:Insulin Delivery, Australia, Distribution Share by Revenue ($m), 2008-2009
Table 35:Insulin Delivery, Australia, Company Share by Revenue ($m), 2008-2009
Table 36: Diabetes Care Devices Pipeline Products
Table 37: USD to Local Currency, Australia, Average Actual Rate 2002-2009

1.2 List of Figures
Figure 1: Diabetes Care Devices, Market Segmentation
Figure 2: Diabetes Care Devices, Australia, Overall Revenue ($m), 2002-2016
Figure 3: Diabetes Care Devices Market, Australia, Revenue Mix ($m), 2009
Figure 4: Diabetes Care Devices Market, Australia, Category Contribution (%), 2009
Figure 5: Diabetes Care Devices, Australia, Cross-Segment Analysis,2002-2016
Figure 6: Diabetes Care Devices, Australia, Overall Revenue ($m), Historic, 2002-2009
Figure 7: Diabetes Care Devices, Australia, Overall Revenue ($m), Forecast, 2009-2016
Figure 8: Diabetes Care Devices, Australia, Category Volume (Units), 2002-2016
Figure 9: Diabetes Care Devices, Australia, Category Volume (Units), Historic, 2002-2009
Figure 10: Diabetes Care Devices, Australia, Category Volume (Units), Forecast, 2009-2016
Figure 11: Diabetes Care Devices, Australia, Company Share (%), 2009
Figure 12: Glucose Monitoring, Market Segmentation
Figure 13: Glucose Monitoring Market, Australia, Revenue Mix ($m), 2009
Figure 14: Glucose Monitoring Market, Australia, Category Contribution (%), 2009
Figure 15: Glucose Monitoring, Australia, Revenue ($m) by Segment, Historic, 2002-2009
Figure 16: Glucose Monitoring, Australia, Revenue ($m) by Segment, Forecast, 2009-2016
Figure 17: Blood Glucose Meters, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 18: Blood Glucose Meters, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 19: Glucose Monitoring, Australia, Volume (Units) by Segment, Historic, 2002-2009
Figure 20: Glucose Monitoring, Australia, Volume (Units) by Segment, Forecast, 2009-2016
Figure 21: Blood Glucose Meters, Australia, Volume (Units) by Sub-Segment, Historic, 2002-2009
Figure 22: Blood Glucose Meters, Australia, Volume (Units) by Sub-Segment, Forecast, 2009-2016
Figure 23: Glucose Monitoring, Australia, Company Share (%), 2009
Figure 24: Insulin Delivery, Market Segmentation
Figure 25: Insulin Delivery Market, Australia, Revenue Mix ($m), 2009
Figure 26: Insulin Delivery Market, Australia, Category Contribution (%), 2009
Figure 27: Insulin Delivery, Australia, Revenue ($m) by Segment, Historic, 2002-2009
Figure 28: Insulin Delivery, Australia, Revenue ($m) by Segment, Forecast, 2009-2016
Figure 29: Insulin Pens, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 30: Insulin Pens, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 31: Insulin Delivery, Australia, Volume (Units) by Segment, Historic, 2002-2009
Figure 32: Insulin Delivery, Australia, Volume (Units) by Segment, Forecast, 2009-2016
Figure 33: Insulin Pens, Australia, Volume (Units) by Sub-Segment, Historic, 2002-2009
Figure 34: Insulin Pens, Australia, Volume (Units) by Sub-Segment, Forecast, 2009-2016
Figure 35: Insulin Delivery, Australia, Company Share (%), 2009
Figure 36: Novo Nordisk A/S, Company Share (%), Australia Diabetes Care Devices Market, 2009
Figure 37: F. Hoffmann-La Roche Ltd, Company Share (%), Australia Diabetes Care Devices Market, 2009
Figure 38: LifeScan, Inc., Company Share (%), Australia Diabetes Care Devices Market, 2009
Figure 39: Sanofi-Aventis, Company Share (%), Australia Diabetes Care Devices Market, 2009
Figure 40: Medtronic, Inc., Company Share (%), Australia Diabetes Care Devices Market, 2009
Figure 41: Eli Lilly and Company, Company Share (%), Australia Diabetes Care Devices Market, 2009
Figure 42: Bayer HealthCare AG, Company Share (%), Australia Diabetes Care Devices Market, 2009
Figure 43: B. Braun Melsungen AG, Company Share (%), Australia Diabetes Care Devices Market, 2009
Figure 44: Abbott Laboratories, Company Share (%), Australia Diabetes Care Devices Market, 2009
Figure 45: GlobalData Methodology

Browse all Medical Devices Market Research Reports at: http://www.reportsandreports.com/market-research/medical-devices/

Browse all GlobalData Market Research Reports at: http://www.reportsandreports.com/Publishers/globaldata/

Related Reports:

http://www.reportsandreports.com/market-reports/japan-diabetes-care-devices-market-outlook-to-2016/

http://www.reportsandreports.com/market-reports/india-diabetes-care-devices-market-outlook-to-2016/

http://www.reportsandreports.com/market-reports/brazil-diabetes-care-devices-market-outlook-to-2016/

About Us:
Reports and Reports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.

Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.reportsandreports.com/
Blog: http://reportsnreports.wordpress.com/